These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28415012)

  • 1. Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.
    Yang L; Ma X; Yuan C; He Y; Li L; Fang S; Xia W; He T; Qian S; Xu Z; Li G; Wang Z
    Eur J Med Chem; 2017 Jul; 134():230-241. PubMed ID: 28415012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.
    Huang S; Song C; Wang X; Zhang G; Wang Y; Jiang X; Sun Q; Huang L; Xiang R; Hu Y; Li L; Yang S
    J Chem Inf Model; 2017 Apr; 57(4):669-679. PubMed ID: 28301150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
    Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
    Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors.
    Khalil NA; Ahmed EM; Zaher AF; El-Zoghbi MS; Sobh EA
    Eur J Med Chem; 2020 Feb; 187():111926. PubMed ID: 31812033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model.
    Di Fruscia P; Zacharioudakis E; Liu C; Moniot S; Laohasinnarong S; Khongkow M; Harrison IF; Koltsida K; Reynolds CR; Schmidtkunz K; Jung M; Chapman KL; Steegborn C; Dexter DT; Sternberg MJ; Lam EW; Fuchter MJ
    ChemMedChem; 2015 Jan; 10(1):69-82. PubMed ID: 25395356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition.
    Kaya SG; Eren G; Massarotti A; Bakar-Ates F; Ozkan E; Gozelle M; Ozkan Y
    Drug Dev Res; 2024 Jun; 85(4):e22224. PubMed ID: 38867474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity.
    Shah AA; Ito A; Nakata A; Yoshida M
    Biol Pharm Bull; 2016; 39(10):1739-1742. PubMed ID: 27725455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
    Cui H; Kamal Z; Ai T; Xu Y; More SS; Wilson DJ; Chen L
    J Med Chem; 2014 Oct; 57(20):8340-57. PubMed ID: 25275824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies.
    Chowdhury S; Sripathy S; Webster A; Park A; Lao U; Hsu JH; Loe T; Bedalov A; Simon JA
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.
    Wang L; Li C; Chen W; Song C; Zhang X; Yang F; Wang C; Zhang Y; Qian S; Wang Z; Yang L
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
    Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
    Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.
    Eren G; Bruno A; Guntekin-Ergun S; Cetin-Atalay R; Ozgencil F; Ozkan Y; Gozelle M; Kaya SG; Costantino G
    J Mol Graph Model; 2019 Jun; 89():60-73. PubMed ID: 30870650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress on the Discovery of Sirt2 Inhibitors for the Treatment of Various Cancers.
    Wang T; Xu Z; Lu Y; Shi J; Liu W; Zhang C; Jiang Z; Qi B; Bai L
    Curr Top Med Chem; 2019; 19(12):1051-1058. PubMed ID: 31074370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New SIRT2 inhibitors: Histidine-based bleomycin spin-off.
    Ali TFS; Ciftci HI; Radwan MO; Koga R; Ohsugi T; Okiyama Y; Honma T; Nakata A; Ito A; Yoshida M; Fujita M; Otsuka M
    Bioorg Med Chem; 2019 May; 27(9):1767-1775. PubMed ID: 30885568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities.
    Spiegelman NA; Price IR; Jing H; Wang M; Yang M; Cao J; Hong JY; Zhang X; Aramsangtienchai P; Sadhukhan S; Lin H
    ChemMedChem; 2018 Sep; 13(18):1890-1894. PubMed ID: 30058233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carprofen analogues as sirtuin inhibitors: enzyme and cellular studies.
    Mellini P; Carafa V; Di Rienzo B; Rotili D; De Vita D; Cirilli R; Gallinella B; Provvisiero DP; Di Maro S; Novellino E; Altucci L; Mai A
    ChemMedChem; 2012 Nov; 7(11):1905-8. PubMed ID: 24155041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition.
    Schnekenburger M; Mathieu V; Lefranc F; Jang JY; Masi M; Kijjoa A; Evidente A; Kim HJ; Kiss R; Dicato M; Han BW; Diederich M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity study of S-trityl-cysteamine dimethylaminopyridine derivatives as SIRT2 inhibitors: Improvement of SIRT2 binding and inhibition.
    Radwan MO; Ciftci HI; Ali TFS; Koga R; Tateishi H; Nakata A; Ito A; Yoshida M; Fujita M; Otsuka M
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127458. PubMed ID: 32755678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.